Back
iShares iBonds Dec 2026 Term Corporate ETF Vs. Novo Nordisk AS Industry Stock Comparison
Buy
56
IBDR
iShares iBonds Dec 2026 Term Corporate ETF
Last Price:
$24.02
Seasonality Move:
-2.03%
Sell
23
NVO
Novo Nordisk AS
Last Price:
$85.00
Seasonality Move:
6.92%
Buy
56
iShares iBonds Dec 2026 Term Corporate ETF (IBDR)
is a Buy
Is iShares iBonds Dec 2026 Term Corporate ETF a Buy, Sell or Hold?
-
The current iShares iBonds Dec 2026 Term Corporate ETF [IBDR] share price is $24.02. The Score for IBDR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
IBDR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IBDR Stock Price Chart
What is iShares iBonds Dec 2026 Term Corporate ETF's stock price today?
-
The iShares iBonds Dec 2026 Term Corporate ETF share price today is $24.02Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBDR is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
IBDR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 38.74 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.05 - 24.13) | Sell |
Bollinger Bands (100): | (24.06 - 24.22) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.5 | Sell |
Relative Strength Index (14 RSI): | 19.69 | Sell |
Chaikin Money Flow: | 20899665 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.63 - 110.99) | Sell |
Bollinger Bands (100): | (107.27 - 131.41) | Sell |
IBDR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.08 | Sell |
20-day SMA: | 24.1 | Sell |
50-day SMA: | 24.11 | Sell |
200-day SMA: | 23.96 | Buy |
8-day EMA: | 24.06 | Sell |
20-day EMA: | 24.08 | Sell |
50-day EMA: | 24.1 | Sell |
200-day EMA: | 23.99 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.71 | Sell |
20-day SMA: | 106.65 | Sell |
50-day SMA: | 109.28 | Sell |
200-day SMA: | 126.25 | Sell |
8-day EMA: | 102.07 | Sell |
20-day EMA: | 105.53 | Sell |
50-day EMA: | 110.02 | Sell |
200-day EMA: | 118.09 | Sell |
iShares iBonds Dec 2026 Term Corporate ETF Earnings Growth & IBDR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.
iShares iBonds Dec 2026 Term Corporate ETF Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |